EP1147193A4 - Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof - Google Patents

Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof

Info

Publication number
EP1147193A4
EP1147193A4 EP00915701A EP00915701A EP1147193A4 EP 1147193 A4 EP1147193 A4 EP 1147193A4 EP 00915701 A EP00915701 A EP 00915701A EP 00915701 A EP00915701 A EP 00915701A EP 1147193 A4 EP1147193 A4 EP 1147193A4
Authority
EP
European Patent Office
Prior art keywords
growth factor
platelet
vascular endothelial
derived
endothelial growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00915701A
Other languages
German (de)
French (fr)
Other versions
EP1147193A1 (en
Inventor
Ulf Eriksson
Kari Alitalo
Juha Lauren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Licentia Oy
Ludwig Institute for Cancer Research New York
Original Assignee
Ludwig Institute for Cancer Research Ltd
Licentia Oy
Ludwig Institute for Cancer Research New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research Ltd, Licentia Oy, Ludwig Institute for Cancer Research New York filed Critical Ludwig Institute for Cancer Research Ltd
Publication of EP1147193A1 publication Critical patent/EP1147193A1/en
Publication of EP1147193A4 publication Critical patent/EP1147193A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP00915701A 1999-01-29 2000-01-28 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof Withdrawn EP1147193A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11786499P 1999-01-29 1999-01-29
US117864P 1999-01-29
PCT/US2000/001895 WO2000044903A1 (en) 1999-01-29 2000-01-28 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof

Publications (2)

Publication Number Publication Date
EP1147193A1 EP1147193A1 (en) 2001-10-24
EP1147193A4 true EP1147193A4 (en) 2003-01-22

Family

ID=22375239

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00915701A Withdrawn EP1147193A4 (en) 1999-01-29 2000-01-28 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof

Country Status (4)

Country Link
EP (1) EP1147193A4 (en)
JP (1) JP2002535006A (en)
AU (1) AU3693000A (en)
WO (1) WO2000044903A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2408507B (en) * 2003-10-06 2005-12-14 Proimmune Ltd Chimeric MHC protein and oligomer thereof for specific targeting
GB2409456B (en) * 2003-10-30 2006-01-04 Proimmune Ltd Oligomeric receptor ligand pair member complexes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996026736A1 (en) * 1995-03-01 1996-09-06 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b
WO1998036052A1 (en) * 1997-02-18 1998-08-20 Ludwig Institute For Cancer Research Transgenic animal with recombinant vascular endothelial growth factor b (vegf-b) dna and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996026736A1 (en) * 1995-03-01 1996-09-06 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b
WO1998036052A1 (en) * 1997-02-18 1998-08-20 Ludwig Institute For Cancer Research Transgenic animal with recombinant vascular endothelial growth factor b (vegf-b) dna and uses thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 11 November 1998 (1998-11-11), XP002218534, Database accession no. AC005948 *
PAAVONEN K ET AL: "NOVEL HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR GENES VEGF-B AND VEGF-C LOCALIZE TO CHROMOSOMES 11Q13 AND 4Q34, RESPECTIVELY", CIRCULATION, vol. 93, no. 6, 15 March 1996 (1996-03-15), pages 1079 - 1082, XP002910091, ISSN: 0009-7322 *
See also references of WO0044903A1 *
UUTELA M ET AL: "Chromosomal location, exon structure, and vascular expression patterns of the human PDGFC and PDGFC genes.", CIRCULATION, vol. 103, no. 18, 8 May 2001 (2001-05-08), pages 2242 - 2247, XP002218533, ISSN: 1524-4539 *

Also Published As

Publication number Publication date
EP1147193A1 (en) 2001-10-24
JP2002535006A (en) 2002-10-22
AU3693000A (en) 2000-08-18
WO2000044903A1 (en) 2000-08-03

Similar Documents

Publication Publication Date Title
AU2002252631A1 (en) Vascular endothelial growth factor 2
EP1313512A4 (en) Vascular endothelial growth factor 2
AU5023300A (en) Vascular endothelial growth factor variants
AU5056501A (en) Fibroblast growth factor-like molecules and uses thereof
EP1062319A4 (en) Vascular endothelial growth factor 2
ZA200108218B (en) Vascular surgery.
AU2002256172A1 (en) Vascular endothelial growth factor 2
AU2000265278A1 (en) Shaped suture clip, appliance and method therefor
AU3301800A (en) 1,4-diazabicyclo(3.2.2)nonane-4-carboxylate and carboxamide derivatives, production and use thereof in therapeutics
AU5439998A (en) Vascular endothelial growth factor
AU3924300A (en) Fibroblast growth factor-20
AU8749198A (en) Deodorant and antimicrobial water absorbent, process for the production thereof and absorbent articles
HUP0200827A3 (en) Vascular endothelial cell growth factor variants and uses thereof
AU2001240149A1 (en) Fibroblast growth factor-like molecules and uses thereof
AU6635800A (en) Pyridomorphinans, thienomoprhinans and use thereof
AU5026100A (en) Vascular endothelial growth factor dimers
AU2002313770A1 (en) Vascular endothelial growth factor 2
GB9907786D0 (en) Intelligent furniture
EP1147193A4 (en) Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof
HU0001397D0 (en) 3-amino-3-arylpropan-1-ol derivatives, production and use thereof
AU5903600A (en) A novel vascular endothelial growth factor family member and uses thereof
AU3614900A (en) Articles with odour control
AU5440800A (en) Fibroblast growth factor 10
AU2001277733A1 (en) Chimeric human-type vascular endothelial cell growth factor
AU3147799A (en) Para-poxvirus-coded vascular endothelial cell growth factor (ppv-vegf)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010813

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: LICENTIA LTD.

Owner name: LUDWIG INSTITUTE FOR CANCER RESEARCH

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12N 15/18 A, 7C 12N 15/63 B, 7C 12N 1/21 B, 7C 12N 5/10 B, 7C 12N 5/16 B, 7A 61K 38/18 B, 7C 07K 14/475 B, 7C 07K 14/49 B, 7C 07K 16/22 B, 7G 01N 33/74 B

A4 Supplementary search report drawn up and despatched

Effective date: 20021211

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030219

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1039147

Country of ref document: HK